FDA Inspection
DAVA Pharmaceuticals, Inc.DAVA Pharmaceuticals, Inc. – FDA Inspection, Mar 3, 2011
Record Details
This FDA Inspection record concerns DAVA Pharmaceuticals, Inc., with an inspection on March 3, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- DAVA Pharmaceuticals, Inc.
- Inspection Date
- March 3, 2011
- Product Type
- Drugs
View Company Profile
ID · ab5adc91-3e6d-4aa5-be5c-f07af547321b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 712093
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
Full citation text and observation details available on the Dashboard.
Other FDA inspections of DAVA Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for DAVA Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.